Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol
Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol
复制标题
DOI:
10.1373/clinchem.2015.238287
复制
发表时间:
2015-06-01
影响因子:
9.3
通讯作者:
Huestis, Marilyn A.
中科院分区:
文献类型:
--
作者:
Hartman, Rebecca L.;Brown, Timothy L.;Huestis, Marilyn A.
BACKGROUND: Increased medical and legal cannabis intake is accompanied by greater use of cannabis vaporization and more cases of driving under the influence of cannabis. Although simultaneous Delta(9)-tetrahydrocannabinol (THC) and alcohol use is frequent, potential pharmacokinetic interactions are poorly understood. Here we studied blood and plasma vaporized cannabinoid disposition, with and without simultaneous oral low-dose alcohol.METHODS: Thirty-two adult cannabis smokers (>= 1 time/3 months, = 1 mu g/L, >= 16.7% of participants remained positive 8.3 h postdose, whereas = 5 mu g/L.CONCLUSIONS: Vaporization is an effective THC delivery route. The significantly higher blood THC and 11-OHTHC Cmax values with alcohol possibly explain increased performance impairment observed from cannabisalcohol combinations. Chosen driving-related THC cutoffs should be considered carefully to best reflect performance impairment windows. Our results will help facilitate forensic interpretation and inform the debate on drugged driving legislation. (C) 2015 American Association for Clinical Chemistry